TCTR20200222003尚未招募4 期
A Randomized, Double-Blind, Crossover, Placebo Controlled Trial of Bacillus clausii in Childhood Constipation
-0 个研究点目标入组 62 人开始时间: 2020年2月22日最近更新:
适应症
试验速览
- 阶段
- 4 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 62
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 1 Years 至 5 Years（—）
- 性别
- All
入选标准
- •Children who was diagnosed constipation by ROME IV criteria.
排除标准
- •Children with suspected or proven organic causes of constipation, use medication causing constipation, receive antibiotic during study, immunocompromised host, neurological impairment and congenital heart disease were excluded
研究者
相似试验
已完成
Unknown
A Stratified Randomized, Double-Blind, Crossover, Placebo-Controlled Clinical Trial for the Evaluation of the Efficacy and Safety of SKH on Hangover ImprovementMental and behavioural disordersKCT0009581Bundang CHA General Hospital30
已完成
不适用
A Crossover designed, Placebo Controlled Study to evaluate the effects of supplement REPHYLL on delayed onset muscle soreness (DOMS) in humans.CTRI/2019/05/019366Aurea Biolabs P Ltd20
进行中（未招募）
不适用
A randomized, double-blind, two way cross-over, proof of concept study to compare the efficacy, safety, pharmacokinetics and pharmacodynamics of two-week oral administration of QAV680 versus placebo, with an extended open-label inhaled corticosteroid period, in steroid-free, mild to moderate persistent asthma patientsEUCTR2008-005168-15-DEovartis Pharma Services AG50
已完成
2 期
Safety , Pharmacokinetics and efficacy of QAV680 in asthma patientsCTRI/2009/091/000282ovartis Healthcare Pvt Ltd50
已完成
不适用
A randomized, double blind, two-way crossover clinical trial to evaluate of pharmacokinetic profiles of lacosamide in Korean subjectsKCT0003959Dong-A University Hospital48